Fidelity Investments’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding MBOT
Fidelity Investments's MBOT Position: Q2 2026 in Review
Fidelity Investments increased its Microbot Medical (MBOT) stake by 7,975% in Q2 2026, buying an estimated $650 and bringing the position to 323 shares worth $630. The position accounts for ﹤0.01% of the portfolio, ranked #5291.
Fidelity Investments first reported a position in MBOT in Q4 2018 and has held it in 17 quarters since. The position peaked at $2K in Q1 2019. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.
- Fidelity Investments held 323 shares of Microbot Medical worth $630 as of Q2 2026.
- Fidelity Investments bought 319 Microbot Medical shares in Q2 2026, an estimated $650.
- Microbot Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5291 holding.
- Fidelity Investments first reported a position in Microbot Medical in Q4 2018 and has held it in 17 quarters since.
- Fidelity Investments's Microbot Medical position peaked at $2K in Q1 2019.
- 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.